DHL Group is set to invest approximately €500 million ($575 million) over the next five years to enhance healthcare logistics services in Africa and the Middle East. This strategic move aims to capitalize on the growing demand for healthcare products, particularly in light of increasing population and healthcare needs in these regions. The investment will focus on specialized logistics for time-sensitive shipments, including vaccines and medical devices, which are critical for improving healthcare delivery.

The company is particularly targeting five key markets: Egypt, Saudi Arabia, Kenya, South Africa, and Dubai. This expansion aligns with a broader global investment strategy of €2 billion in healthcare logistics, with Africa and the Middle East expected to receive about 25% of this funding. The initiative is also a response to the rising demand for pharmaceuticals in Africa, projected to reach $33.8 billion by 2030, indicating a significant growth opportunity for DHL in the healthcare sector.